Delivery Order SPE2DB20D2001-SPE2DB22FM40J

Award Date 2/1/22
Potential Completion Date 2/2/22
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of FORTESTA 10 MG GEL PUMP 60GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,455.47, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued up to $999,999,999.00 and expiring on December 31, 2025. This IDC serves...
This federal contract award is for the delivery of FORTESTA 10 MG GEL PUMP 60GM pharmaceutical products to the U.S. government. The award, with a ceiling value of $1,512.31, was made to Amerisourcebergen Drug Corp, Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to federal agencies. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to...
This federal contract award is for the delivery of FORTESTA 10 MG GEL PUMP 60GM to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 25, 2022 with a ceiling value of $9,497.48. It is a firm fixed-price delivery order contract with an ultimate completion date of January 26, 2022. The contract does not have a set-aside designation, indicating it was competed...
This federal contract award is for the supply of FORTESTA 10 MG GEL PUMP 60GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on October 11, 2022 with a ceiling value of $1,265.61. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award, valued at $1,353.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of FORTESTA 10 MG GEL PUMP 60GM, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The award has an ultimate completion date of November 7, 2022. There is no set-aside designation mentioned for this contract. Amerisourcebergen Drug Corp is a subsidiary...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,091.32 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of FORTESTA 10 MG GEL PUMP 60GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical through December 31, 2025. The IDC enables DLA to efficiently procure a wide range of pharmaceutical products and medical supplies, including...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,252.34 firm fixed-price contract is for the delivery of FORTESTA 10 MG GEL PUMP 60GM, a pharmaceutical product, with a period of performance through September 27, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,079.66, is for the delivery of FORTESTA 10 MG GEL PUMP 60GM, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc., for the supply of FORTESTA 10 MG GEL PUMP 60GM. The Firm Fixed Price contract, worth $2,044.82, was awarded on October 25, 2021, with an ultimate completion date of October 26, 2021. This Delivery Order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of FORTESTA 10 MG GEL PUMP 60GM. The award, valued at $1,365.44, is a firm fixed-price contract with a completion date of January 20, 2022. This contract is not designated as a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB22FM40J
    Delivery Order

This federal contract award is for the delivery of FORTESTA 10 MG GEL PUMP 60GM pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,189.00, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. This award supports the DLA's medical supply procurement for the U.S. Department of Defense and its healthcare programs, ensuring the availability of critical pharmaceutical products for military personnel and veterans.

Generated 2/27/25, 12:22 PM